StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed operating margin

Operating margin is operating income as a percentage of revenue.

CervoMed's operating margin for the twelve months ending Jun 30, 2026 was -9407.0%. For fiscal 2025 it was -706.2%, against -187.2% the year before. The highest annual figure on record is -109.3% in fiscal 2023.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-706.2%−519.0
FY2024Dec 31, 2024-187.2%−77.8
FY2023Dec 31, 2023-109.3%+17746.2
FY2013Dec 31, 2013-17855.5%−14707.2
FY2012Dec 31, 2012-3148.3%−268.4
FY2011Dec 31, 2011-2879.9%+16122.7
FY2010Dec 31, 2010-19002.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-95479.2%−95144.3
Q3 FY2025Sep 30, 2025-2493.8%−2215.6
Q2 FY2025Jun 30, 2025-376.4%−285.3
Q1 FY2025Mar 31, 2025-276.6%−166.0
Q4 FY2024Dec 31, 2024-334.9%−235.3
Q3 FY2024Sep 30, 2024-278.2%−102.9
Q2 FY2024Jun 30, 2024-91.1%−19.5
Q1 FY2024Mar 31, 2024-110.6%−9.2
Q4 FY2023Dec 31, 2023-99.6%–
Q3 FY2023Sep 30, 2023-175.2%–
Q2 FY2023Jun 30, 2023-71.6%–
Q1 FY2023Mar 31, 2023-101.3%–

More CervoMed figures

See a number that looks wrong?